Patent Theme
Internal Fluid Management Devices
Implantable devices designed to manage or redirect bodily fluids, including stents for ducts, and systems for draining or accumulating fluids within internal cavities.
8,831 US filings from 1,997 companies since 2023 · 2023: 2,192 · 2024: 2,854 · 2025: 2,752 · 2026 YTD: 1,033
Implants & Prosthetics
Top companies
Ranked by filings in this theme since 2023. 2026 is partial.
| # | Company | Since 2023 | 2023 | 2024 | 2025 | 2026 YTD | YoY |
|---|
| 1 | Boston Scientific Scimed, Inc. | 837 | 162 | 270 | 282 | 123 | +4.4% |
| 2 | PUREWICK CORPORATION | 189 | 26 | 63 | 72 | 28 | +14.3% |
| 3 | Covidien LP | 179 | 68 | 58 | 45 | 8 | -22.4% |
| 4 | Coloplast A/S | 157 | 43 | 57 | 47 | 10 | -17.5% |
| 5 | Hollister Incorporated | 124 | 38 | 37 | 33 | 16 | -10.8% |
| 6 | CAREFUSION 303, INC. | 102 | 27 | 32 | 31 | 12 | -3.1% |
| 7 | C. R. Bard, Inc. | 99 | 22 | 34 | 34 | 9 | 0.0% |
| 8 | W. L. Gore & Associates, Inc. | 96 | 35 | 25 | 26 | 10 | +4.0% |
| 9 | BAXTER INTERNATIONAL INC. | 93 | 20 | 26 | 33 | 14 | +26.9% |
| 10 | Becton, Dickinson and Company | 93 | 28 | 35 | 19 | 11 | -45.7% |
| 11 | BAXTER HEALTHCARE SA | 88 | 20 | 23 | 32 | 13 | +39.1% |
| 12 | Stryker Corporation | 86 | 18 | 20 | 40 | 8 | +100.0% |
| 13 | DePuy Synthes Products, Inc. | 77 | 31 | 28 | 14 | 4 | -50.0% |
| 14 | TERUMO KABUSHIKI KAISHA | 75 | 25 | 17 | 22 | 11 | +29.4% |
| 15 | Shifamed Holdings, LLC | 70 | 16 | 18 | 22 | 14 | +22.2% |
| 16 | CONVATEC LIMITED | 66 | 11 | 21 | 21 | 13 | 0.0% |
| 17 | St. Jude Medical, Cardiology Division, Inc. | 64 | 6 | 21 | 28 | 9 | +33.3% |
| 18 | Boston Scientific Medical Device Limited | 63 | 6 | 19 | 32 | 6 | +68.4% |
| 19 | MicroVention, Inc. | 60 | 18 | 19 | 17 | 6 | -10.5% |
| 20 | Cilag GmbH International | 54 | 22 | 11 | 14 | 7 | +27.3% |
| 21 | OLYMPUS CORPORATION | 50 | 10 | 20 | 13 | 7 | -35.0% |
| 22 | COOK MEDICAL TECHNOLOGIES LLC | 48 | 18 | 16 | 11 | 3 | -31.2% |
| 23 | DEKA Products Limited Partnership | 48 | 5 | 12 | 23 | 8 | +91.7% |
| 24 | Edwards Lifesciences Corporation | 47 | 9 | 15 | 20 | 3 | +33.3% |
| 25 | Medline Industries, LP | 47 | 13 | 12 | 17 | 5 | +41.7% |